Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy
Clinical trial NCT07185945 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07185945
- Sponsor
- Guru Sonpavde
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-06-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.